ES2194992T3 - Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas. - Google Patents

Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas.

Info

Publication number
ES2194992T3
ES2194992T3 ES96917569T ES96917569T ES2194992T3 ES 2194992 T3 ES2194992 T3 ES 2194992T3 ES 96917569 T ES96917569 T ES 96917569T ES 96917569 T ES96917569 T ES 96917569T ES 2194992 T3 ES2194992 T3 ES 2194992T3
Authority
ES
Spain
Prior art keywords
compositions
substances
procedures
vitreas
matrices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96917569T
Other languages
English (en)
Inventor
Bruce Joseph Roser
Enda Martin Gribbon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2194992(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Application granted granted Critical
Publication of ES2194992T3 publication Critical patent/ES2194992T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LA INVENCION DESCRIBE PROCEDIMIENTOS PARA PRODUCIR VIDRIO CELULAR Y LAS COMPOSICIONES QUE SE OBTIENEN MEDIANTE ESTOS. LAS COMPOSICIONES RESULTAN ADECUADAS PARA EL ALMACENAJE ESTABLE DE UNA AMPLIA DIVERSIDAD DE SUSTANCIAS, EN PARTICULAR BIOLOGICAS Y FARMACEUTICAS.
ES96917569T 1995-06-07 1996-06-07 Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas. Expired - Lifetime ES2194992T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
ES2194992T3 true ES2194992T3 (es) 2003-12-01

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96917569T Expired - Lifetime ES2194992T3 (es) 1995-06-07 1996-06-07 Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas.

Country Status (22)

Country Link
EP (1) EP0831790B1 (es)
JP (1) JP4502406B2 (es)
KR (1) KR19990022710A (es)
CN (1) CN1245957C (es)
AP (1) AP852A (es)
AT (1) ATE239451T1 (es)
AU (1) AU713599B2 (es)
BR (1) BR9609188A (es)
CA (1) CA2223438C (es)
CZ (1) CZ391297A3 (es)
DE (1) DE69628007T2 (es)
DK (1) DK0831790T3 (es)
ES (1) ES2194992T3 (es)
HU (1) HUP9901716A3 (es)
IL (1) IL122482A (es)
MX (1) MX9709716A (es)
NO (1) NO975773L (es)
NZ (1) NZ309841A (es)
PL (1) PL184823B1 (es)
PT (1) PT831790E (es)
SK (1) SK167597A3 (es)
WO (1) WO1996040077A2 (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332105T2 (de) 1992-09-29 2003-03-06 Inhale Therapeutic Systems, San Carlos Pulmonale abgabe von aktiven fragmenten des parathormons
EP0748213B1 (en) 1994-03-07 2004-04-14 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
CN1188171C (zh) 1994-06-02 2005-02-09 廓德伦特控股剑桥有限公司 防止各种特质在再水化或熔化时聚集的方法以及由此获得的组合物
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
AU5459698A (en) * 1997-11-26 1999-06-15 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1071465A1 (en) * 1998-03-18 2001-01-31 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
CN1433465A (zh) * 1999-05-04 2003-07-30 埃里克·爱德华·沃勒尔 保存病毒和支原体的方法
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
CA2382061A1 (en) * 1999-08-19 2001-02-22 Victor Bronshtein Preservation of bacterial cells at ambient temperatures
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1296656E (pt) 2000-06-27 2006-12-29 Hoffmann La Roche Processo para a preparação de uma composição
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
WO2003041637A2 (en) * 2001-11-09 2003-05-22 Centocor, Inc. Lyophilized monoclonal antibody compositions
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
DK1556477T3 (en) * 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
EP1758937B1 (en) * 2004-05-24 2009-09-02 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form
EP1750760B1 (en) 2004-06-02 2017-06-28 Universal Stabilization Technologies, Inc. Preservation by vaporization
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
KR101540920B1 (ko) 2007-07-26 2015-08-03 사노피 파스퇴르 리미티드 항원-애주번트 조성물 및 방법
US8283165B2 (en) 2008-09-12 2012-10-09 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
KR101799983B1 (ko) 2009-05-26 2017-12-20 어드밴스드 바이오뉴트리션 코프. 생물학적 활성 미생물 및/또는 생활성 물질을 포함하는 안정한 건식분말 조성물 및 제조 방법
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
US20120219590A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
EP3449938A1 (en) * 2011-05-17 2019-03-06 Soligenix, Inc. Thermostable vaccine compositions and methods of preparing same
PE20191242A1 (es) 2011-10-25 2019-09-16 Prothena Biosciences Ltd Formulaciones de anticuerpo y metodos
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
BR112018001784B1 (pt) 2015-07-29 2022-05-10 Advanced Bionutrition Corp Composições probióticas secas estáveis para usos dietéticos especiais, seu método de preparação e método de preparação de uma fórmula para bebês
ES2818569T3 (es) * 2015-09-09 2021-04-13 Drawbridge Health Inc Métodos para la recopilación, estabilización y conservación de muestras
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
SG10201911879UA (en) 2017-01-10 2020-01-30 Drawbridge Health Inc Devices, systems, and methods for sample collection
CN117050969B (zh) * 2023-08-18 2024-04-02 北京中检葆泰生物技术有限公司 一种碱性磷酸酶的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
JPS6115830A (ja) * 1984-06-28 1986-01-23 ザ　プロクタ−　アンド　ガンブル　カンパニ− 制酸剤組成物およびその製造方法
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
AU634227B2 (en) * 1989-05-01 1993-02-18 Baxter International Inc. Composition of beneficial agent and method for administering the same by controlled dissolution
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
ES2090714T3 (es) * 1991-12-05 1996-10-16 Mallinckrodt Veterinary Inc Matriz de vidrio de carbohidrato para la liberacion prolongada de un agente terapeutico.
ES2096103T3 (es) * 1992-01-13 1997-03-01 Pfizer Preparacion de comprimidos de resistencia incrementada.
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica

Also Published As

Publication number Publication date
DE69628007T2 (de) 2003-11-27
CN1193908A (zh) 1998-09-23
IL122482A (en) 1999-10-28
EP0831790B1 (en) 2003-05-07
JP4502406B2 (ja) 2010-07-14
PT831790E (pt) 2003-07-31
CN1245957C (zh) 2006-03-22
AP852A (en) 2000-06-16
HUP9901716A2 (hu) 1999-09-28
NO975773D0 (no) 1997-12-08
HUP9901716A3 (en) 2000-04-28
MX9709716A (es) 1998-03-31
CA2223438C (en) 2008-05-13
AP9701151A0 (en) 1998-01-31
SK167597A3 (en) 1998-10-07
AU713599B2 (en) 1999-12-09
CA2223438A1 (en) 1996-12-19
KR19990022710A (ko) 1999-03-25
JPH11506467A (ja) 1999-06-08
DK0831790T3 (da) 2003-09-01
AU6009896A (en) 1996-12-30
CZ391297A3 (cs) 1998-05-13
ATE239451T1 (de) 2003-05-15
WO1996040077A3 (en) 1997-01-23
EP0831790A2 (en) 1998-04-01
IL122482A0 (en) 1998-06-15
BR9609188A (pt) 1999-05-11
PL323902A1 (en) 1998-04-27
DE69628007D1 (de) 2003-06-12
WO1996040077A2 (en) 1996-12-19
NZ309841A (en) 1999-10-28
PL184823B1 (pl) 2002-12-31
NO975773L (no) 1998-02-03

Similar Documents

Publication Publication Date Title
ES2194992T3 (es) Procedimientos para la incorporacion estable de sustancias en matrices vitreas secas esponjosas, y composiciones asi obtenidas.
HN1999000075A (es) Agonistas y antagonistas il-2 selectivos
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ES2195664T3 (es) Uso de fumaratos de dialquilo.
ES2162284T3 (es) Proceso para la fabricacion de tensioactivos que contienen grupos alquilo de cadena ramificada.
ES2164286T3 (es) Emplasto con sustancias activas.
IL117425A0 (en) Receptor activation by gas6
ES2173314T3 (es) Metodos y composiciones para la modificacion selectiva de acidos nucleicos.
GT199700015A (es) Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion.
WO2002061111A3 (en) Room temperature stable competent cells
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
ES2114198T3 (es) Placas de plastico celular obtenidas con empleo de propulsantes exentos de halogeno.
ES2167784T3 (es) Copolimeros reticulados a base de polimeros policarboxilicos.
AU4578199A (en) Gel matrix non-emulsion composition containing two clay gels
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
ID24185A (id) Pelet matriks polietilena glikol untuk bahan obat yang berlemak, berminyak atau lengket
ES2176961T3 (es) Mezclas solidas a base de sulfonilureas y adyuvantes.
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
WO1997012985A3 (en) Multi-functional hematopoietic receptor agonists
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
AR020779A1 (es) Materiales y metodos para la modificacion de los polisacaridos de las paredes celulares de las plantas
BR0008035A (pt) Composições isoladas de células de planta e seu uso na modificação de sinalização de célula de planta
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ES2177987T3 (es) Articulos moldeados de celulosa hidratada con superficie enzimaticamente modificada.
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.